An ADHD drug with a black box FDA warning got recalled. Metal was embedded in a tablet

Jun 04, 2024

A medication used to treat attention deficit/hyperactivity disorder (ADHD) and narcolepsy carries the FDA’s most serious warning, but got recalled for another reason: metal was found embedded in a tablet.

Sun Pharma has yanked one lot of 20 mg Methylphenidate Hydrochloride tablets. The 7,313 100-count bottles in lot No. AC74459 with expiration date 07/31/2024 were distributed nationwide. The tablets are described by the U.S. National Library of Medicine as being round with a flat face, beveled edge, no coating. On one side is “230” and on the other side is an “S” and a “20” separated by a line. The color is “light peach.”

READ MORE: The boxes said they contained mental health meds. They actually had drugs for AIDS and cancer patients

If you have one of these bottles, return them to your pharmacist and inform the prescribing medical professional.

Methylphenidate Hydrochloride tablets have an FDA black box warning for doctors that the drug has “a high potential for abuse and dependence. Assess the risk of abuse prior to prescribing, and monitor for signs of abuse and dependence while on therapy.”

If you have had any medical problems from this or any other drug, see a medical professional. Then, let the FDA know via its MedWatch Adverse Event page or by filling out a form you can get by calling 800-332-1088.